Evidence map›Paper›PMID 34636967›Full record

ArticleActa neurochirurgica2022

Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum.

Meng Cui, Hewen Chen, Guochen Sun, Jialin Liu, Meng Zhang, Hepu Lin, Caihong Sun, Xiaodong Ma

Open access · hybridAbstract read
In one paragraph

Article in Acta neurochirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Splenial lesions of the corpus callosum: a comprehensive study on etiology, clinical presentation, radiological features, and prognostic insights.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Meng CuiMedical School of Chinese PLA, Beijing, 100853, China.ORCID http://orcid.org/0000-0002-6337-9711
Hewen ChenMedical School of Chinese PLA, Beijing, 100853, China.
Guochen SunDepartment of Neurosurgery, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Jialin LiuDepartment of Neurosurgery, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Meng ZhangMedical School of Chinese PLA, Beijing, 100853, China.
Hepu LinDepartment of Neurosurgery, the Seventh Medical Center, Chinese PLA General Hospital, Beijing, 100700, China.
Caihong SunDepartment of Neurosurgery, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Xiaodong MaMedical School of Chinese PLA, Beijing, 100853, China. xiaodongm@hotmail.com.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare the multimodal techniques (including neuronavigation, intraoperative MRI [iMRI], and neuromonitoring [IONM]) and conventional approach (only guided by neuronavigation) in removing glioblastoma (GBM) with corpus callosum (CC) involvement (ccGBM), their effectiveness and safety were analyzed and compared.

methodsElectronic medical records were retrospectively reviewed for ccGBM cases treated in our hospital between January 2016 and July 2020. Patient demographics, tumor characteristics, clinical outcomes, extent of resection (EOR), progression-free survival (PFS), and overall survival (OS) were obtained and compared between the multimodal group (used multimodal techniques) and the conventional group (only used neuronavigation). Both groups only included patients that had maximal safe resection (not biopsy). Postoperative radiochemotherapy was also performed or not. Univariate and multivariate analyses were performed to identify significant prognostic factors and optimal EOR threshold.

resultsFinally 56 cases of the multimodal group and 21 cases of the conventional group were included. The multimodal group achieved a higher median EOR (100% versus 96.1%, P = 0.036) and gross total resection rate (60.7% versus 33.3%, P = 0.032) and a lower rate of permanent motor deficits (5.4% versus 23.8%, P = 0.052) than the conventional approach. The multimodal group had the longer median PFS (10.9 versus 7.0 months, P = 0.023) and OS (16.1 versus 11.6 months, P = 0.044) than the conventional group. Postoperative language and cognitive function were similar between the two groups. In multivariate analysis, a higher EOR, radiotherapy, and longer cycles of temozolomide chemotherapy were positive prognostic factors for survival of ccGBM. An optimal EOR threshold of 92% was found to significantly benefit the PFS (HR = 0.51, P = 0.036) and OS (HR = 0.49, P = 0.025) of ccGBM.

conclusionCombined use of multimodal techniques can optimize the safe removal of ccGBM. Aggressive resection of EOR > 92% using multimodal techniques combined with postoperative radiochemotherapy should be suggested for ccGBM.

Indexed as

Brain NeoplasmsGlioblastomaCorpus CallosumHumansMagnetic Resonance ImagingMonitoring, IntraoperativeNeurosurgical ProceduresRetrospective StudiesTreatment OutcomeCorpus callosumGlioblastomaIntraoperative magnetic resonanceIntraoperative neuromonitoringNeuronavigationSurvival

Identifiers

PMID34636967
PMCPMC8913450
OpenAlexW3205356776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.